← Open Payments lookup

OLUKEMI ADEOGUN: Open Payments

NPI 1780991083 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$619 in 20 payments from 10 companies in 2025. Trend: 2023 $123 · 2024 $94 · 2025 $619

Food & beverage: $518Education: $101
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.8$245
Axsome Therapeutics, Inc.1$120
E.R. Squibb & Sons, L.L.C.2$49
Otsuka America Pharmaceutical, Inc.2$42
Janssen Pharmaceuticals, Inc2$33
Neurocrine BioSciences, Inc.1$30
Lundbeck LLC1$28
ABBVIE INC.1$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23
Alkermes, Inc.1$21

Products named: Auvelity, UZEDY, COBENFY, ABILIFY ASIMTUFII, INVEGA SUSTENNA, INGREZZA, VRAYLAR, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.